Thus, it is possible that in PCa, and in the absence of androgens, EGFR is overexpressed in prostate tumours facilitating glucose transport into cells by associating with and stabilising an SGLT1 without requiring EGFR kinase activity as proposed by Weihua et al (2008). The gene discussed is SLC5A1; the disease is posterior cortical atrophy.